- Home
- ASRT vs PAVS Comparison
ASRT vs PAVS Comparison
Compare ASRT & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- PAVS
- Stock Information
- Founded
- ASRT 1995
- PAVS 2004
- Country
- ASRT United States
- PAVS United States
- Employees
- ASRT N/A
- PAVS N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- PAVS Medicinal Chemicals and Botanical Products
- Sector
- ASRT Health Care
- PAVS Health Care
- Exchange
- ASRT Nasdaq
- PAVS Nasdaq
- Market Cap
- ASRT 79.1M
- PAVS 66.3M
- IPO Year
- ASRT 1997
- PAVS 2019
- Fundamental
- Price
- ASRT $0.81
- PAVS $0.77
- Analyst Decision
- ASRT Strong Buy
- PAVS
- Analyst Count
- ASRT 1
- PAVS 0
- Target Price
- ASRT $3.00
- PAVS N/A
- AVG Volume (30 Days)
- ASRT 289.6K
- PAVS 6.8K
- Earning Date
- ASRT 08-11-2025
- PAVS 08-04-2025
- Dividend Yield
- ASRT N/A
- PAVS N/A
- EPS Growth
- ASRT N/A
- PAVS N/A
- EPS
- ASRT N/A
- PAVS N/A
- Revenue
- ASRT $117,099,000.00
- PAVS $71,542.00
- Revenue This Year
- ASRT N/A
- PAVS N/A
- Revenue Next Year
- ASRT $11.91
- PAVS N/A
- P/E Ratio
- ASRT N/A
- PAVS N/A
- Revenue Growth
- ASRT N/A
- PAVS N/A
- 52 Week Low
- ASRT $0.51
- PAVS $0.32
- 52 Week High
- ASRT $1.38
- PAVS $1.50
- Technical
- Relative Strength Index (RSI)
- ASRT 66.13
- PAVS 45.11
- Support Level
- ASRT $0.71
- PAVS $0.70
- Resistance Level
- ASRT $0.86
- PAVS $0.82
- Average True Range (ATR)
- ASRT 0.03
- PAVS 0.09
- MACD
- ASRT 0.01
- PAVS -0.01
- Stochastic Oscillator
- ASRT 70.69
- PAVS 20.56
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.